Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 574

1.

Intraoperative sonography in patients with colorectal cancer and resectable liver metastases on preoperative FDG-PET-CT.

Wildi SM, Gubler C, Hany T, Petrowsky H, Clavien PA, Jochum W, Gerlach T, Fried M, Mullhaupt B.

J Clin Ultrasound. 2008 Jan;36(1):20-6.

PMID:
17937421
2.

Comparison of multiphase CT, FDG-PET and intra-operative ultrasound in patients with colorectal liver metastases selected for surgery.

Wiering B, Ruers TJ, Krabbe PF, Dekker HM, Oyen WJ.

Ann Surg Oncol. 2007 Feb;14(2):818-26. Epub 2006 Nov 29.

PMID:
17136470
3.

Preoperative staging of liver metastases from uveal melanoma by magnetic resonance imaging (MRI) and fluorodeoxyglucose-positron emission tomography (FDG-PET).

Servois V, Mariani P, Malhaire C, Petras S, Piperno-Neumann S, Plancher C, Levy-Gabriel C, Lumbroso-le Rouic L, Desjardins L, Salmon RJ.

Eur J Surg Oncol. 2010 Feb;36(2):189-94. doi: 10.1016/j.ejso.2009.08.010. Epub 2009 Sep 22.

PMID:
19775851
4.

Impact of whole-body imaging on treatment decision to radio-frequency ablation in patients with malignant liver tumors: comparison of [18F]fluorodeoxyglucose-PET/computed tomography, PET and computed tomography.

Kuehl H, Rosenbaum-Krumme S, Veit-Haibach P, Stergar H, Forsting M, Bockisch A, Antoch G.

Nucl Med Commun. 2008 Jul;29(7):599-606. doi: 10.1097/MNM.0b013e3282f8144d.

PMID:
18528181
5.
6.

The evolving role of staging laparoscopy in the treatment of colorectal hepatic metastasis.

Thaler K, Kanneganti S, Khajanchee Y, Wilson C, Swanstrom L, Hansen PD.

Arch Surg. 2005 Aug;140(8):727-34.

PMID:
16103281
7.

18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.

Sperti C, Bissoli S, Pasquali C, Frison L, Liessi G, Chierichetti F, Pedrazzoli S.

Ann Surg. 2007 Dec;246(6):932-7; discussion 937-9.

PMID:
18043094
8.

Prospective evaluation of CECT and 18F-FDG-PET/CT in detection of hepatic metastases.

D'souza MM, Sharma R, Mondal A, Jaimini A, Tripathi M, Saw SK, Singh D, Mishra A, Tripathi RP.

Nucl Med Commun. 2009 Feb;30(2):117-25. doi: 10.1097/MNM.0b013e32831ec57b.

PMID:
19057427
9.

Does the novel PET/CT imaging modality impact on the treatment of patients with metastatic colorectal cancer of the liver?

Selzner M, Hany TF, Wildbrett P, McCormack L, Kadry Z, Clavien PA.

Ann Surg. 2004 Dec;240(6):1027-34; discussion 1035-6.

10.

Liver lesion detection and characterization in patients with colorectal cancer: a comparison of low radiation dose non-enhanced PET/CT, contrast-enhanced PET/CT, and liver MRI.

Cantwell CP, Setty BN, Holalkere N, Sahani DV, Fischman AJ, Blake MA.

J Comput Assist Tomogr. 2008 Sep-Oct;32(5):738-44. doi: 10.1097/RCT.0b013e3181591d33.

PMID:
18830103
11.

Contrast-enhanced 18F-FDG PET/CT: 1-stop-shop imaging for assessing the resectability of pancreatic cancer.

Strobel K, Heinrich S, Bhure U, Soyka J, Veit-Haibach P, Pestalozzi BC, Clavien PA, Hany TF.

J Nucl Med. 2008 Sep;49(9):1408-13. doi: 10.2967/jnumed.108.051466. Epub 2008 Aug 14.

12.

[Use of PET-CT in pre-surgical staging of colorectal cancer hepatic metastases].

Ramos E, Martínez L, Gámez C, Torras J, Valls C, Rafecas A, Lladó L, Jorba R, Ruiz S, Serrano T, Fabregat J.

Cir Esp. 2008 Aug;84(2):71-7. Spanish.

13.

Performance of integrated FDG-PET/contrast-enhanced CT in the staging and restaging of colorectal cancer: comparison with PET and enhanced CT.

Dirisamer A, Halpern BS, Flöry D, Wolf F, Beheshti M, Mayerhoefer ME, Langsteger W.

Eur J Radiol. 2010 Feb;73(2):324-8. doi: 10.1016/j.ejrad.2008.10.030. Epub 2009 Feb 5.

PMID:
19200683
14.

Staging pathways in recurrent colorectal carcinoma: is contrast-enhanced 18F-FDG PET/CT the diagnostic tool of choice?

Soyka JD, Veit-Haibach P, Strobel K, Breitenstein S, Tschopp A, Mende KA, Lago MP, Hany TF.

J Nucl Med. 2008 Mar;49(3):354-61. doi: 10.2967/jnumed.107.048249. Epub 2008 Feb 20.

15.

F18-FDG-PET evaluation of patients for resection of colorectal liver metastases.

Huguet EL, Old S, Praseedom RK, Balan KK, Gibbs P, Jamieson NV.

Hepatogastroenterology. 2007 Sep;54(78):1667-71.

PMID:
18019690
16.
18.

Is there a role for fluorodeoxyglucose positron emission tomography/computed tomography in cytologically indeterminate thyroid nodules?

Hales NW, Krempl GA, Medina JE.

Am J Otolaryngol. 2008 Mar-Apr;29(2):113-8. doi: 10.1016/j.amjoto.2007.04.006.

PMID:
18314022
19.

Usefulness of intraoperative sonography for revealing hepatic metastases from colorectal cancer in patients selected for surgery after undergoing FDG PET.

Rydzewski B, Dehdashti F, Gordon BA, Teefey SA, Strasberg SM, Siegel BA.

AJR Am J Roentgenol. 2002 Feb;178(2):353-8.

PMID:
11804891
20.

Impact of 18F-FDG PET/CT on therapeutic decisions in patients with colorectal cancer and liver metastases.

Georgakopoulos A, Pianou N, Kelekis N, Chatziioannou S.

Clin Imaging. 2013 May-Jun;37(3):536-41. doi: 10.1016/j.clinimag.2012.09.011. Epub 2012 Oct 30.

PMID:
23116727

Supplemental Content

Support Center